Learn More
Medchemexpress LLC TTA-P2 | 1072018-68-8 | 99.6% | 431.37 g/mol | C21H29Cl2FN2O2 | 1 MG

Supplier: Medchemexpress LLC HY100351MG
TTA-P2 is a research-grade small-molecule inhibitor of T-type (Cav3) calcium channels. It is selective, orally active, and blood-brain barrier permeant, with reported potency (IC50 ≈ 22 nM). Common applications include electrophysiology, studies of neuronal excitability, and in vivo pain and epilepsy models.
- Selective T-type calcium channel blocker with nanomolar potency.
- Orally active and blood-brain barrier permeant.
- Suitable for electrophysiology and in vivo neurological models.
- Well characterized in pain and epilepsy research literature.
- Supplied in solid form and in ready-to-use DMSO solution formats.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.